Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791204 · ClinicalTrials.gov registry record
SPECT/CT Imaging of Skeletal Muscle Perfusion
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 34
- Enrollment target
NCT02791204 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 34 participants.
The verdict
NCT02791204 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
This study will use SPECT/CT imaging to assess the effect of percutaneous revascularization treatments in patients with Peripheral arterial disease and diabetes mellitus, in whom the disease can progress more quickly than in patients without diabetes.
Interventions
- DEVICE SPECT/CT imaging following revascularization procedures
- DEVICE SPECT/CT imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-05 |
| Est. Completion | 2026-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02791204
The ClinicalTrials.gov registry entry for NCT02791204 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SPECT/CT imaging following revascularization procedures is the first listed.
NCT02791204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02791204 about?
NCT02791204 is a clinical study titled "SPECT/CT Imaging of Skeletal Muscle Perfusion". This study will use SPECT/CT imaging to assess the effect of percutaneous revascularization treatments in patients with Peripheral arterial disease and diabetes mellitus, in whom the disease can progress more quickly than in patients without diabetes.
What is the current status of trial NCT02791204?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-05. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT02791204?
The interventions under investigation include: SPECT/CT imaging following revascularization procedures (DEVICE), SPECT/CT imaging (DEVICE).
Who is sponsoring clinical trial NCT02791204?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.